Atai Life Sciences plans to merge with psychedelic startup Beckley Psytech
The new company will be known as Atai Beckley… …with Beckley Psytech shareholders receiving 31% of shares in the entity… Beckley’s lead program is a synthetic, intranasal form of 5-meo-dmt… Original Artic (Stat News):Atai Life Sciences plans to merge with psychedelic startup Beckley PsytechArtwork Fair Use: Jynto
Recent Comments